share_log

Monitoring Cardiac Symptoms? HeartBeam Extends Pact With Samsung For LIVMOR Solutions

Monitoring Cardiac Symptoms? HeartBeam Extends Pact With Samsung For LIVMOR Solutions

监测心脏症状？HeartBeam 延长了与三星在 LIVMOR 解决方案
Benzinga ·  2023/05/30 12:03
  • HeartBeam, Inc. (NASDAQ:BEAT) shares are trading higher after entering a strategic alliance agreement with Samsung Electronics Co Ltd (OTC:SSNGY) (OTC:SSNLF).
  • The deal extends the existing pact between HeartBeam's recently-acquired LIVMOR and Samsung. The financial terms were not disclosed.
  • Under the latest deal, HeartBeam and Samsung will assess and monitor cardiac symptoms, tapping the HeartBeam's patented technology.
  • "Our newly acquired state of the art, FDA cleared, Samsung watch-based arrhythmia detection tool, once integrated with the HeartBeam AIMIGo telehealth platform, presents a unique opportunity to extend our product capabilities well beyond what is currently available for cardiac patients outside of a medical setting," said Branislav Vajdic, Ph.D., HeartBeam CEO and Founder.
  • HeartBeam acquired the assets of LIVMOR earlier this year. Founded in 2016, LIVMOR developed the Halo Atrial Fibrillation (AF) Detection System, the world's first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring.
  • The potential of combining LIVMOR's technology and the HeartBeam AIMIGo system holds significant promise to address primary cardiac conditions for veterans.
  • Price Action: BEAT shares are trading higher by 7.6% to $2.34 on the last check Tuesday.
  • HeartBeam, Inc 纳斯达克股票代码：BEAT）在与达成战略联盟协议后，股价走高 三星电子有限公司 (OTC: SSNGY) (OTC: SSNLF)。
  • 该交易延长了HeartBeam最近收购的LIVMOR与三星之间的现有协议。财务条款未披露。
  • 根据最新协议，HeartBeam和三星将利用HeartBeam的专利技术评估和监测心脏症状。
  • HeartBeam首席执行官兼创始人布拉尼斯拉夫·瓦伊迪奇博士说：“我们新收购的最先进的、经美国食品药品管理局批准的基于三星手表的心律失常检测工具一旦与HeartBeam AimiGo远程医疗平台集成，为我们的产品能力提供了一个难得的机会。”
  • HeartBeam在今年早些时候收购了LIVMOR的资产。LIVMOR 成立于 2016 年，开发了 Halo 心房颤动 (AF) 检测系统，这是世界上第一款经美国食品药品管理局批准的用于持续心律监测的处方可穿戴设备。
  • 将LIVMOR的技术与HeartBeam AimiGo系统相结合的潜力为退伍军人解决原发性心脏病带来了巨大希望。
  • 价格走势： 在周二的最后一张支票中，BEAT股价上涨了7.6％，至2.34美元。
声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发